Literature DB >> 29271100

Managing opioid overdose in pregnancy with take-home naloxone.

Julie Blandthorn1, Ellen Bowman1,2, Laura Leung3, Yvonne Bonomo1,4,5, Paul Dietze6,7.   

Abstract

Programs have recently been established in Australia and internationally to allow wider access to naloxone to people at risk of opioid overdose yet there are no guidelines relating to the administration of naloxone to pregnant women, particularly regarding dose requirements and resuscitative measures peculiar to pregnancy. This paper provides practical guidelines to health workers in relation to any complications that may arise during opioid overdose response (including the administration of naloxone) for pregnant women and the follow up required ensuring best possible outcomes for mother and baby.
© 2017 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  naloxone; opioids; overdose; pregnancy; resuscitation

Mesh:

Substances:

Year:  2017        PMID: 29271100     DOI: 10.1111/ajo.12761

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  3 in total

1.  A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs.

Authors:  Hawraa Sameer Sajwani; Anna V Williams
Journal:  Harm Reduct J       Date:  2022-10-20

Review 2.  Pregnancy-Associated Deaths from Homicide, Suicide, and Drug Overdose: Review of Research and the Intersection with Intimate Partner Violence.

Authors:  Jacquelyn Campbell; Sabrina Matoff-Stepp; Martha L Velez; Helen Hunter Cox; Kathryn Laughon
Journal:  J Womens Health (Larchmt)       Date:  2020-12-08       Impact factor: 2.681

3.  Opioid poisoning during pregnancy: prevalence, characteristics, and neonatal outcomes.

Authors:  Erin Kelty; Anwyn Pyle; David B Preen
Journal:  Arch Womens Ment Health       Date:  2022-08-19       Impact factor: 4.405

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.